- Home
- SYRE vs SKE Comparison
SYRE vs SKE Comparison
Compare SYRE & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | SKE |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | SKE |
|---|---|---|
| Price | $33.03 | $24.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $56.50 | N/A |
| AVG Volume (30 Days) | ★ 925.8K | 843.1K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.91 | $8.53 |
| 52 Week High | $35.31 | $26.05 |
Technical Indicators
Market Signals| Indicator | SYRE | SKE |
|---|---|---|
| Relative Strength Index (RSI) | 62.10 | 66.92 |
| Support Level | $32.50 | $23.21 |
| Resistance Level | $34.84 | $24.98 |
| Average True Range (ATR) | 1.48 | 1.11 |
| MACD | -0.37 | -0.04 |
| Stochastic Oscillator | 25.90 | 64.54 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SKE Skeena Resources Limited
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.